The Department of Defense is offering the NOW grant to develop a mobile medical countermeasure manufacturing platform for rapid production of nucleic acid therapeutics within 24 hours. The goal is to create a resilient, mobile system for immediate threat response in stabilization and humanitarian operations, requiring minimal user intervention. This grant aims to enhance the military’s ability to produce and deploy nucleic acid MCMs efficiently in diverse operational environments. Closing date for applications: Jan 09, 2020.
Opportunity ID: 321643
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HR001120S0006 |
| Funding Opportunity Title: | Nucleic Acids On-Demand World-Wide (NOW) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Oct 16, 2019 |
| Last Updated Date: | Nov 25, 2019 |
| Original Closing Date for Applications: | Jan 09, 2020 See Full Announcement for details. |
| Current Closing Date for Applications: | Jan 09, 2020 See Full Announcement for details. |
| Archive Date: | Feb 08, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | All responsible sources capable of satisfying the Government’s needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information. |
Additional Information
| Agency Name: | DARPA – Biological Technologies Office |
| Description: | The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention. |
| Link to Additional Information: | FedBizOpps Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA Coordinator
NOW@darpa.mil Email:NOW@darpa.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The purpose of Amendment 1 to HR001120S0006, the Nucleic Acids on Demand Worldwide (NOW) Broad Agency Announcement, is to clarify the size, weight, and power (SWAP) specifications and update the General Requirements. | Nov 25, 2019 | |
| Oct 16, 2019 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HR001120S0006 |
| Funding Opportunity Title: | Nucleic Acids On-Demand World-Wide (NOW) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Oct 16, 2019 |
| Last Updated Date: | Nov 25, 2019 |
| Original Closing Date for Applications: | Jan 09, 2020 See Full Announcement for details. |
| Current Closing Date for Applications: | Jan 09, 2020 See Full Announcement for details. |
| Archive Date: | Feb 08, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | All responsible sources capable of satisfying the Government’s needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information. |
Additional Information
| Agency Name: | DARPA – Biological Technologies Office |
| Description: | The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention. |
| Link to Additional Information: | FedBizOpps Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA Coordinator
NOW@darpa.mil Email:NOW@darpa.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HR001120S0006 |
| Funding Opportunity Title: | Nucleic Acids On-Demand World-Wide (NOW) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 16, 2019 |
| Last Updated Date: | Oct 16, 2019 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 09, 2020 See Full Announcement for details. |
| Archive Date: | Feb 08, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | All responsible sources capable of satisfying the Government’s needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information. |
Additional Information
| Agency Name: | DARPA – Biological Technologies Office |
| Description: | The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention. |
| Link to Additional Information: | FedBizOpps Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA Coordinator
NOW@darpa.mil Email:NOW@darpa.mil |
Related Documents
Folder 321643 Full Announcement-HR001120S0006 -> Attachment 2_HR001119S0095-SOW_Template.pdf
Folder 321643 Full Announcement-HR001120S0006 -> Attachment 1_HR001119S0095-Executive_Summary_Slide_Template.pdf
Folder 321643 Full Announcement-HR001120S0006 -> Attachment 3_HR001119S0095-Budget_Template.pdf
Folder 321643 Full Announcement-HR001120S0006 -> HR001120S0006.pdf
Folder 321643 Revised Full Announcement-HR001120S0006-Amendment-01 -> HR001120S0006-Amendment-01.pdf
Packages
| Agency Contact Information: | BAA Coordinator NOW@darpa.mil Email: NOW@darpa.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.910 | PKG00255886 | Nov 25, 2019 | Jan 09, 2020 | View |
Package 1
Mandatory forms
321643 RR_SF424_2_0-2.0.pdf
321643 AttachmentForm_1_2-1.2.pdf
321643 RR_KeyPersonExpanded_2_0-2.0.pdf
321643 RR_PersonalData_1_2-1.2.pdf
Optional forms
321643 SFLLL_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
